Home / Companies / Legend Biotech Corporation / 21 Oct 2024
Legend Biotech Corporation: meeting of 21 Oct 2024
Votes reported on Form N-PX, item by item
131 Form N-PX filers reported votes at the Legend Biotech Corporation meeting of 21 Oct 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 74.2% of reported votes for; 110 filers withheld from or voted against at least one nominee.
924 vote records from 131 filers. 6 of the 131 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
231 vote records from 131 filers. 1 of the 131 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
231 vote records from 131 filers. 7 of the 131 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
442 vote records from 131 filers. 1 of the 131 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
20 vote records from 15 filers. 0 of the 15 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| State Street and SPDR | For | For |
| American Century | For | For |
| Franklin Templeton | For | For |
| Invesco | For | For |
| Equitable | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Goldman Sachs | For | For |
| WisdomTree | For | For |
| PGIM and Prudential | For | For |
| Jackson National funds | For | For |
| Northern Trust and FlexShares | Split or no vote | For |
| T. Rowe Price | For | For |
| Thrivent | For | For |
| Lincoln Financial | For | For |
| Voya | For | For |
| First Trust | For | For |
| Russell Investments | For | For |
| Nationwide | For | For |
| Victory Capital | For | For |
| Brighthouse Funds | For | For |
| Guggenheim and Rydex | For | For |
| Columbia Threadneedle | For | For |
| Principal | For | For |
| Capital Group and American Funds | For | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| MFS | For | For |
| Federated Hermes | For | For |
| AllianceBernstein | Against * | For |
| Hartford Funds | For | For |
| MassMutual | For | For |
| Harbor Funds | For | For |
| Janus Henderson | For | For |
| Artisan Partners | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Legend Biotech Corporation meeting?
131 Form N-PX filers reported votes at the meeting of 21 Oct 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Legend Biotech Corporation on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Legend Biotech Corporation
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Legend Biotech Corporation with a meeting date within three days of 21 Oct 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.